Pharmacokinetics of azlocillin in normal renal function: Single and repetitive dosing studies

Fernando A. Delgado, Robert L. Stout, Andrew Whelton

Research output: Contribution to journalArticle

Abstract

Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seven male and six female healthy volunteers. Four separate studies identified the kinetics of the drug following a single 2, 3 or 4 g administration and during the repetitive administrations of 3 g of the drug over a five-day period. Peak plasma concentrations were 174 ± 19 mg/l, 214 + 17 mg/l and 286 + 11 mg/l in the 2, 3 and 4 g single dose studies respectively. Trough values at 4 h post-dosing were 6 ± 1 mg/l, 10 ± 1 mg/l and 26 ± 3 mg/l respectively. ±The plasma half-life of azlocillin was approximately 60 min. A dose-dependent phenomenon was observed. This was characterized by a slight but significant progressive increase in the plasma half-life of the drug as increasing amounts of drug were given and as the same amount was given repeatedly. No significant systemic accumulation of azlocillin was noted during the repetitive dosing study. The urinary excretion of the compound was prompt with most of the bioactive drug being eliminated in the first 4–6 h following dosing. The apparent volume of distribution of azlocillin was slightly greater than the extracellular fluid compartment. For the therapy of systemic infections in adults with normal renal function a 4 h or 6 h dosing cycle would be appropriate.

Original languageEnglish (US)
Pages (from-to)79-88
Number of pages10
JournalThe Journal of antimicrobial chemotherapy
Volume11
DOIs
StatePublished - 1983

Fingerprint

Azlocillin
Pharmacokinetics
Kidney
Pharmaceutical Preparations
Half-Life
Extracellular Fluid
Healthy Volunteers
Infection

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)
  • Microbiology

Cite this

Pharmacokinetics of azlocillin in normal renal function : Single and repetitive dosing studies. / Delgado, Fernando A.; Stout, Robert L.; Whelton, Andrew.

In: The Journal of antimicrobial chemotherapy, Vol. 11, 1983, p. 79-88.

Research output: Contribution to journalArticle

Delgado, Fernando A. ; Stout, Robert L. ; Whelton, Andrew. / Pharmacokinetics of azlocillin in normal renal function : Single and repetitive dosing studies. In: The Journal of antimicrobial chemotherapy. 1983 ; Vol. 11. pp. 79-88.
@article{710f3e6adf7044f68a5b5048a87594d4,
title = "Pharmacokinetics of azlocillin in normal renal function: Single and repetitive dosing studies",
abstract = "Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seven male and six female healthy volunteers. Four separate studies identified the kinetics of the drug following a single 2, 3 or 4 g administration and during the repetitive administrations of 3 g of the drug over a five-day period. Peak plasma concentrations were 174 ± 19 mg/l, 214 + 17 mg/l and 286 + 11 mg/l in the 2, 3 and 4 g single dose studies respectively. Trough values at 4 h post-dosing were 6 ± 1 mg/l, 10 ± 1 mg/l and 26 ± 3 mg/l respectively. ±The plasma half-life of azlocillin was approximately 60 min. A dose-dependent phenomenon was observed. This was characterized by a slight but significant progressive increase in the plasma half-life of the drug as increasing amounts of drug were given and as the same amount was given repeatedly. No significant systemic accumulation of azlocillin was noted during the repetitive dosing study. The urinary excretion of the compound was prompt with most of the bioactive drug being eliminated in the first 4–6 h following dosing. The apparent volume of distribution of azlocillin was slightly greater than the extracellular fluid compartment. For the therapy of systemic infections in adults with normal renal function a 4 h or 6 h dosing cycle would be appropriate.",
author = "Delgado, {Fernando A.} and Stout, {Robert L.} and Andrew Whelton",
year = "1983",
doi = "10.1093/jac/11.suppl_B.79",
language = "English (US)",
volume = "11",
pages = "79--88",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Pharmacokinetics of azlocillin in normal renal function

T2 - Single and repetitive dosing studies

AU - Delgado, Fernando A.

AU - Stout, Robert L.

AU - Whelton, Andrew

PY - 1983

Y1 - 1983

N2 - Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seven male and six female healthy volunteers. Four separate studies identified the kinetics of the drug following a single 2, 3 or 4 g administration and during the repetitive administrations of 3 g of the drug over a five-day period. Peak plasma concentrations were 174 ± 19 mg/l, 214 + 17 mg/l and 286 + 11 mg/l in the 2, 3 and 4 g single dose studies respectively. Trough values at 4 h post-dosing were 6 ± 1 mg/l, 10 ± 1 mg/l and 26 ± 3 mg/l respectively. ±The plasma half-life of azlocillin was approximately 60 min. A dose-dependent phenomenon was observed. This was characterized by a slight but significant progressive increase in the plasma half-life of the drug as increasing amounts of drug were given and as the same amount was given repeatedly. No significant systemic accumulation of azlocillin was noted during the repetitive dosing study. The urinary excretion of the compound was prompt with most of the bioactive drug being eliminated in the first 4–6 h following dosing. The apparent volume of distribution of azlocillin was slightly greater than the extracellular fluid compartment. For the therapy of systemic infections in adults with normal renal function a 4 h or 6 h dosing cycle would be appropriate.

AB - Systemic and urinary pharmacokinetic studies of the disposition of azlocillin were performed in seven male and six female healthy volunteers. Four separate studies identified the kinetics of the drug following a single 2, 3 or 4 g administration and during the repetitive administrations of 3 g of the drug over a five-day period. Peak plasma concentrations were 174 ± 19 mg/l, 214 + 17 mg/l and 286 + 11 mg/l in the 2, 3 and 4 g single dose studies respectively. Trough values at 4 h post-dosing were 6 ± 1 mg/l, 10 ± 1 mg/l and 26 ± 3 mg/l respectively. ±The plasma half-life of azlocillin was approximately 60 min. A dose-dependent phenomenon was observed. This was characterized by a slight but significant progressive increase in the plasma half-life of the drug as increasing amounts of drug were given and as the same amount was given repeatedly. No significant systemic accumulation of azlocillin was noted during the repetitive dosing study. The urinary excretion of the compound was prompt with most of the bioactive drug being eliminated in the first 4–6 h following dosing. The apparent volume of distribution of azlocillin was slightly greater than the extracellular fluid compartment. For the therapy of systemic infections in adults with normal renal function a 4 h or 6 h dosing cycle would be appropriate.

UR - http://www.scopus.com/inward/record.url?scp=0020755740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020755740&partnerID=8YFLogxK

U2 - 10.1093/jac/11.suppl_B.79

DO - 10.1093/jac/11.suppl_B.79

M3 - Article

C2 - 6619035

AN - SCOPUS:0020755740

VL - 11

SP - 79

EP - 88

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

ER -